Clinical Trials in San Antonio

Showing 12421-12440 of 12,572 trials

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

NCT00012558

A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.

National Institute of Mental Health (NIMH)5,000 participantsStarted Sep 1998

Stanford, California, United States • Denver, Colorado, United States • Boston, Massachusetts, United States +8 more locations

COMPLETEDPhase 2< 1 mile

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

NCT00051051

CI-1033 is an experimental drug that acts as an inhibitor of erbB (EGFR) receptors, which may be involved in tumor growth. The primary objective of this study is to assess the antitumor activity of CI-1033 in patients with metastatic breast cancer. Patients with histologically confirmed metastatic (Stage IV) breast cancer and who have received no more than 2 prior cytotoxic chemotherapy regimens are eligible for this study. CI-1033 is administered orally. Patients are required to have blood tests periodically while receiving treatment and will be closely monitored throughout the study for possible side effects and response to treatment. Patients may not have received any prior treatment with other agents that target erbB receptors, including Herceptin (trastuzumab) or Iressa (gefitinib).

Breast Neoplasms

Pfizer168 participantsStarted Dec 2002

Montgomery, Alabama, United States • Arroyo Grande, California, United States • Montebello, California, United States +63 more locations

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Find Trials by Condition in San Antonio

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

US Inhaled Insulin Therapeutic Choice Questionnaire Study

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Amonafide in Combination With Cytarabine in Secondary AML

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Buprenorphine and Integrated HIV Care Evaluation

Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response